Rankings
▼
Calendar
TGTX FY 2017 Earnings — TG Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
TGTX
TG Therapeutics, Inc.
$5B
FY 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$152,381
+0.0% YoY
Gross Profit
$70,026
46.0% margin
Operating Income
-$119M
-77904.6% margin
Net Income
-$118M
-77749.9% margin
EPS (Diluted)
$-1.91
Cash Flow
Operating Cash Flow
-$94M
Free Cash Flow
-$94M
Stock-Based Comp.
$16M
Balance Sheet
Total Assets
$97M
Total Liabilities
$97M
Stockholders' Equity
$67M
Cash & Equivalents
$57M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$152,381
$152,381
+0.0%
Gross Profit
$70,026
$89,421
-21.7%
Operating Income
-$119M
-$79M
-50.3%
Net Income
-$118M
-$78M
-51.4%
← Q4 2016
All Quarters
Q1 2017 →